ID
41658
Description
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Subject Diary) is to be filled out by study participant between Visit 1 (Screening) and Visit 2 (Randomization), between Visit 2 (Randomization) and Visit 3, between Visit 3 and Visit 4, between Visit 4 and Visit 5 and between Visit 5 and Visit 6. Daily Diary Instructions: Reminders: (for patient) - Bring this Diary and all study medication to each clinic visit. - Do not take any new medications without first contacting the study doctor. - Do not write your name or initials anywhere on this diary. (paper-pen specific) - Withhold albuterol for at least 6 hours prior to your next clinic visit. If you have taken albuterol within 6 hours prior to a visit, contact the clinic to reschedule the visit. - Complete the Medical Problems/Medications Taken Worksheet if you experience any medical problems and take medication(s) for the problem(s). - Withhold your morning dose of blinded study medication prior to the next clinic visit. IF you have taken your morning dose of blinded study medication prior to a visit contact the clinic to reschedule the visit. (NOT applicable for Subject Diary 1) - Record all medical problems which may have occurred on that date, AND all medication(s) you (the subject) took on that date to treat the problem. General rules for Diary completion: - Print neatly using only black or blue ink. Do NOT use pencil. (paper-pen specific) - Draw one line through any changes or mistakes and re-enter the correct information above/beside. (paper-pen specific) - DO NOT use correction fluid or tape. (paper-pen specific) Record the following information in this diary every day. 1. Date. Record dates in DD MMM YY format (for example: 15. OCT 08). 2. Daily Albuterol Use. If you required rescue albuterol for COPD symptoms during the last 24 hour period, record the total number of puffs administered. If none, enter zero (0). 3. Daily Albuterol Nebel Use. If you required rescue albuterol nebulas for COPD symptoms during the last 24 hour period, record the total number of nebulas administered. If none, enter zero (0). 4.1. Morning (AM) Study Medication Taken. Each morning (approximately 6:00-9:00 AM) take 1 inhalation from the SPIRIVA HANDIHALER Device. Record the total number of inhalations of open-blind study medication you took each day from the SPIRIVA HANDIHALER Device. (applicable only for Subject Diary 1) 4.2. Morning (AM) and Evening (PM) Study Medication Taken. Each morning (approximately 6:00-9:00 AM) take 1 inhalation from the DISKUS followed by 1 inhalation from the SPIRIVA HANDIHALER Device. Each evening (approximately 6:00-9:00 PM) approximately 12 hours after the morning dosing with the DISKUS, take 1 inhalation from the DISKUS. Record the total number of inhalations of double-blind study medication you took each day from the DISKUS and the total number of inhalations of open-blind study medication you took each day from the SPIRIVA HANDIHALER Device. (applicable for Subject Diaries 2-5) 5. Medical Problems/Medications Taken Worksheet. Record all medical problems which may have occurred on that date, AND all medication(s) you took on that date to treat the problem on the separate Medical Problems/Medication Taken Worksheet page. Do not include study-related medications.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Keywords
Versions (3)
- 12/1/20 12/1/20 -
- 12/5/20 12/5/20 -
- 12/5/20 12/5/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 5, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Subject Diary
- StudyEvent: ODM
Description
Subject Daily Diary
Alias
- UMLS CUI-1
- C3890583
- UMLS CUI-2
- C0332173
Description
Date of assessment
Data type
date
Alias
- UMLS CUI [1]
- C2985720
Description
Number of puffs of rescue albuterol taken during the last 24 hours
Data type
integer
Alias
- UMLS CUI [1,1]
- C0884980
- UMLS CUI [1,2]
- C0001927
- UMLS CUI [1,3]
- C1533107
- UMLS CUI [1,4]
- C1442770
Description
Number of rescue albuterol nebules used during the last 24 hours
Data type
integer
Alias
- UMLS CUI [1,1]
- C0884980
- UMLS CUI [1,2]
- C0001927
- UMLS CUI [1,3]
- C2347333
- UMLS CUI [1,4]
- C1442770
Description
Number of inhalations of open-label SPIRIVA HANDIHALER study medication taken during the last 24 hours
Data type
integer
Alias
- UMLS CUI [1,1]
- C0001559
- UMLS CUI [1,2]
- C1705566
- UMLS CUI [1,3]
- C1442770
- UMLS CUI [1,4]
- C1306772
Description
NOT applicable for Subject Diary 1 (between Visit 1 and Visit 2)
Data type
integer
Alias
- UMLS CUI [1,1]
- C0001559
- UMLS CUI [1,2]
- C1705566
- UMLS CUI [1,3]
- C1442770
- UMLS CUI [1,4]
- C0304229
Description
Medical Problems/Medication taken
Alias
- UMLS CUI-1
- C1254481
- UMLS CUI-2
- C3890583
- UMLS CUI-3
- C0013227
Description
Medical Problem
Data type
text
Alias
- UMLS CUI [1]
- C3540840
- UMLS CUI [2]
- C0012634
Description
Date Medical Problem Started
Data type
date
Alias
- UMLS CUI [1,1]
- C3540840
- UMLS CUI [1,2]
- C0808070
- UMLS CUI [2,1]
- C0012634
- UMLS CUI [2,2]
- C0808070
Description
Date Medical Problem Stopped
Data type
date
Alias
- UMLS CUI [1,1]
- C3540840
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C0012634
- UMLS CUI [2,2]
- C0806020
Description
Medication(s) Taken for Medical Problem
Data type
text
Alias
- UMLS CUI [1,1]
- C3540840
- UMLS CUI [1,2]
- C0013227
- UMLS CUI [2,1]
- C0012634
- UMLS CUI [2,2]
- C0013227
Description
Date Medication Started
Data type
date
Alias
- UMLS CUI [1]
- C3173309
Description
Date Medication Stopped
Data type
date
Alias
- UMLS CUI [1]
- C1531784
Similar models
Subject Diary
- StudyEvent: ODM
C0008976 (UMLS CUI [1,2])
C2825164 (UMLS CUI [1,2])
C0001927 (UMLS CUI [1,2])
C1533107 (UMLS CUI [1,3])
C1442770 (UMLS CUI [1,4])
C0001927 (UMLS CUI [1,2])
C2347333 (UMLS CUI [1,3])
C1442770 (UMLS CUI [1,4])
C1705566 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C1306772 (UMLS CUI [1,4])
C1705566 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,4])
C3890583 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0012634 (UMLS CUI [2])
C0808070 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0808070 (UMLS CUI [2,2])
C0806020 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0806020 (UMLS CUI [2,2])
C0013227 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
No comments